USA ADP Employment Change for Jun 692.000 thousand vs 600.000 thousand consensus estimate. The prior reading was 978.000 thousand.
SVB Leerink Maintains Outperform on Innate Pharma, Raises Price Target to $9
SVB Leerink analyst Daina Graybosch maintains Innate Pharma (NASDAQ:IPHA) with a Outperform and raises the price target from $7 to $9.